Oaktree Acquisition Corp. II
Status: Closed Deal
U=S+W/4
W=S@11.50
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Sep 17, 2020 |
| CEO | Alexander Taubman |
| Left Lead | Deutsche Bank |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Industrial ▶ |
| IPO Geography | Global |
| Target Company | Alvotech |
| Deal Announced | Dec 7, 2021 |
| Deal Size, $M | $2,250.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jun 7, 2022 |
| Amendment Vote | TBD |
| Closing Date | Jun 15, 2022 |
Formerly OACB
ALVO
ALVOW
| Price | $7.95 |
|---|---|
| Last closing price | $8.11 |
| H/L, today | $7.78 / $8.11 |
| H/L, 52-week | $5.56 / $14.60 |
| Volume, today | 67,163 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.